TNFRSF11B and celiac disease: Current evidence in the medical literature supports that osteoprotegerin (OPG) is associated with bone metabolism abnormalities in celiac disease, including altered bone mineral density (BMD) and increased bone turnover, but does not establish OPG as an independent predictor of delayed bone age in pediatric celiac disease.